| scholarly article | Q13442814 |
| P2093 | author name string | Michael Davis | |
| Kerry J Ressler | |||
| David L Walker | |||
| Kwok-Tung Lu | |||
| P2860 | cites work | A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia | Q77805002 |
| Genetic enhancement of learning and memory in mice | Q22010371 | ||
| From normal fear to pathological anxiety. | Q29026708 | ||
| Why we think plasticity underlying Pavlovian fear conditioning occurs in the basolateral amygdala | Q33684057 | ||
| Neuroanatomical hypothesis of panic disorder, revised | Q33876547 | ||
| Psychosocial treatment of posttraumatic stress disorder | Q33889854 | ||
| A modern learning theory perspective on the etiology of panic disorder | Q34158821 | ||
| Extinction of fear-potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala | Q34242260 | ||
| Does modulation of glutamatergic function represent a viable therapeutic strategy in Alzheimer's disease? | Q35252608 | ||
| Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats | Q35874724 | ||
| New mechanisms of excitatory transmitter neurotoxicity. | Q40608891 | ||
| Psychosocial treatment of phobia and panic disorders. | Q40638672 | ||
| Imagery in human classical conditioning | Q41516532 | ||
| Actions of D-cycloserine at the N-methyl-D-aspartate-associated glycine receptor site in vivo | Q41910958 | ||
| D-cycloserine blocks the effects of ethanol and HA-966 in rats tested in the elevated plus-maze | Q42671161 | ||
| Mitogen-activated protein kinase cascade in the basolateral nucleus of amygdala is involved in extinction of fear-potentiated startle. | Q43687987 | ||
| Acquisition of contextual Pavlovian fear conditioning is blocked by application of an NMDA receptor antagonist D,L-2-amino-5-phosphonovaleric acid to the basolateral amygdala | Q44006052 | ||
| D-cycloserine: a ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristics | Q44802121 | ||
| Hippocampus-dependent learning facilitated by a monoclonal antibody or D-cycloserine | Q44905163 | ||
| Blocking of acquisition but not expression of conditioned fear-potentiated startle by NMDA antagonists in the amygdala | Q45180522 | ||
| N-methyl-D-aspartate receptors in the basolateral amygdala are required for both acquisition and expression of conditional fear in rats. | Q45930455 | ||
| Amygdalar NMDA receptors are critical for new fear learning in previously fear-conditioned rats. | Q48380126 | ||
| Anticonflict effect of the glycineB receptor partial agonist, D-cycloserine, in rats. Pharmacological analysis | Q48697404 | ||
| D-cycloserine acts as a partial agonist at the glycine modulatory site of the NMDA receptor expressed in Xenopus oocytes | Q49095632 | ||
| Involvement of NMDA receptors within the amygdala in short- versus long-term memory for fear conditioning as assessed with fear-potentiated startle | Q49112177 | ||
| Activation of ERK/MAP kinase in the amygdala is required for memory consolidation of pavlovian fear conditioning. | Q51074301 | ||
| Current approaches to etiology and pathophysiology of specific phobia. | Q51092876 | ||
| Anxiolytic activity of glycine-B antagonists and partial agonists--no relation to intrinsic activity in the patch clamp. | Q51099873 | ||
| The NMDA antagonist MK-801 blocks the extinction of Pavlovian fear conditioning. | Q51113315 | ||
| Fear-potentiated startle in posttraumatic stress disorder. | Q51121545 | ||
| Fear conditioning, pre-pulse inhibition and drug modulation of a short latency startle response measured electromyographically from neck muscles in the rat. | Q51215608 | ||
| d-Cycloserine: effects on long-term retention of a conditioned response and on memory for contextual attributes. | Q51980663 | ||
| Effects of post-training infusions of a mitogen-activated protein kinase kinase inhibitor into the hippocampus or entorhinal cortex on short- and long-term retention of inhibitory avoidance. | Q52027439 | ||
| Improved cognition in Alzheimer's disease with short-term D-cycloserine treatment. | Q52035005 | ||
| Manipulation of NMDA-receptor activity alters extinction of an instrumental response in rats. | Q52037586 | ||
| Enhancement of intermediate-term memory by an alpha-1 agonist or a partial agonist at the glycine site of the NMDA receptor. | Q52045293 | ||
| The effects of D-cycloserine and MK-801 on the performance of rats in two spatial learning and memory tasks. | Q52050605 | ||
| Acute but not chronic activation of the NMDA-coupled glycine receptor with D-cycloserine facilitates learning and retention. | Q52057976 | ||
| Effect on memory processing by D-cycloserine, an agonist of the NMDA/glycine receptor | Q52087911 | ||
| D-cycloserine, a positive modulator of the N-methyl-D-aspartate receptor, enhances performance of learning tasks in rats. | Q52112971 | ||
| Time-dependent impairment of inhibitory avoidance retention in rats by posttraining infusion of a mitogen-activated protein kinase kinase inhibitor into cortical and limbic structures. | Q52170746 | ||
| D-cycloserine, a partial agonist at the glycine site coupled to N-methyl-D-aspartate receptors, improves visual recognition memory in rhesus monkeys. | Q52200518 | ||
| d-Cycloserine enhances implicit memory in Alzheimer patients. | Q52202939 | ||
| The NMDA receptor antagonist MK-801 blocks acquisition and extinction of conditioned hypoalgesic responses in the rat. | Q52216914 | ||
| Amelioration of negative symptoms in schizophrenia by glycine. | Q54198258 | ||
| Effects of putative cognition enhancers on the NMDA receptor by [3H]MK801 binding | Q70788111 | ||
| Kinetic study of the interactions between the glutamate and glycine recognition sites on the N-methyl-D-aspartic acid receptor complex | Q72377410 | ||
| Anxiolytic-like effects of N-methyl-D-aspartate-associated glycine receptor ligands in the rat potentiated startle test | Q72669225 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cycloserine | Q418508 |
| P304 | page(s) | 2343-2351 | |
| P577 | publication date | 2002-03-01 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats | |
| P478 | volume | 22 |
| Q37491511 | A bout of voluntary running enhances context conditioned fear, its extinction, and its reconsolidation |
| Q36005220 | A controlled trial of the adjunct use of D-cycloserine to facilitate cognitive behavioral therapy outcomes in a cocaine-dependent population |
| Q37625601 | A large QTL for fear and anxiety mapped using an F2 cross can be dissected into multiple smaller QTLs. |
| Q39783270 | A pilot study of the effectiveness of D-cycloserine during cue-exposure therapy in abstinent alcohol-dependent subjects |
| Q30275402 | A randomized placebo-controlled pilot study of the efficacy and safety of D-cycloserine in people with chronic back pain |
| Q30585383 | A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans |
| Q33878972 | A requirement for memory retrieval during and after long-term extinction learning |
| Q47973852 | A return to the psychiatric dark ages with a two-system framework for fear. |
| Q34357046 | A role beyond learning for NMDA receptors in reward-based decision-making-a pharmacological study using d-cycloserine. |
| Q30475995 | A role for alpha-adrenergic receptors in extinction of conditioned fear and cocaine conditioned place preference |
| Q42949863 | A within-subject cognitive battery in the rat: differential effects of NMDA receptor antagonists |
| Q30499662 | AX+, BX- discrimination learning in the fear-potentiated startle paradigm: possible relevance to inhibitory fear learning in extinction |
| Q48314739 | Acquisition of fear extinction requires activation of NR2B-containing NMDA receptors in the lateral amygdala. |
| Q30501683 | Activation of group II metabotropic glutamate receptors induces depotentiation in amygdala slices and reduces fear-potentiated startle in rats |
| Q50756425 | Acute systemic fibroblast growth factor-2 enhances long-term extinction of fear and reduces reinstatement in rats. |
| Q39427245 | Acute, but not chronic, exposure to d-cycloserine facilitates extinction and modulates spontaneous recovery of a conditioned taste aversion |
| Q90678506 | Administration of a delta opioid receptor agonist KNT-127 to the basolateral amygdala has robust anxiolytic-like effects in rats |
| Q37827822 | Advances in pharmacotherapy for pediatric anxiety disorders |
| Q30457479 | Advances in the treatment of anxiety: targeting glutamate |
| Q37257029 | Advances in the treatment of pediatric obsessive-compulsive d-cycloserine with exposure and response prevention. |
| Q43272463 | Alterations of excitatory transmission in the lateral amygdala during expression and extinction of fear memory |
| Q33908155 | Amphetamine and extinction of cued fear. |
| Q36925580 | Amygdala BDNF signaling is required for consolidation but not encoding of extinction |
| Q30483357 | Amygdala intercalated neurons are required for expression of fear extinction |
| Q47658025 | Amygdaloid zif268 participated in the D-cycloserine facilitation effect on the extinction of conditioned fear |
| Q91866855 | An Emergent Discriminative Learning Is Elicited During Multifrequency Testing |
| Q35551573 | An N-methyl-D-aspartate receptor agonist facilitates sleep-independent synaptic plasticity associated with working memory capacity enhancement |
| Q30375098 | An Overview of Translationally Informed Treatments for Posttraumatic Stress Disorder: Animal Models of Pavlovian Fear Conditioning to Human Clinical Trials |
| Q43186100 | An fMRI study examining effects of acute D-cycloserine during symptom provocation in spider phobia |
| Q35176167 | Animal models of anxiety disorders |
| Q26783191 | Animal models of obsessive-compulsive disorder: utility and limitations |
| Q48123253 | Antagonism at NMDA receptors, but not β-adrenergic receptors, disrupts the reconsolidation of pavlovian conditioned approach and instrumental transfer for ethanol-associated conditioned stimuli |
| Q42121362 | Anti-dyskinetic mechanisms of amantadine and dextromethorphan in the 6-OHDA rat model of Parkinson's disease: role of NMDA vs. 5-HT1A receptors |
| Q39845463 | Anxioselective profile of glycineB receptor partial agonist, d-cycloserine, in plus-maze-naïve but not plus-maze-experienced mice |
| Q38430438 | Augmentation of Evidence-Based Psychotherapy for PTSD With Cognitive Enhancers |
| Q24187995 | Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders |
| Q37066267 | Augmentation of exposure therapy with post-session administration of D-cycloserine |
| Q46681201 | Augmentation of fear extinction by D-cycloserine is blocked by proteasome inhibitors |
| Q24240358 | Augmentation of psychotherapy with d-cycloserine for anxiety disorders |
| Q24684778 | Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine |
| Q30358603 | Baseline psychophysiological and cortisol reactivity as a predictor of PTSD treatment outcome in virtual reality exposure therapy. |
| Q30524657 | Behavioral analysis of NR2C knockout mouse reveals deficit in acquisition of conditioned fear and working memory |
| Q28215414 | Behavioral and neural analysis of extinction |
| Q27001253 | Behavioral and neurobiological mechanisms of extinction in Pavlovian and instrumental learning |
| Q42263567 | Behavioural memory reconsolidation of food and fear memories |
| Q36401781 | Behavioural pharmacology: 40+ years of progress, with a focus on glutamate receptors and cognition |
| Q30473410 | Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia |
| Q34517093 | Bidirectional effects of inhibiting or potentiating NMDA receptors on extinction after cocaine self-administration in rats |
| Q44209093 | Bidirectional synaptic plasticity in intercalated amygdala neurons and the extinction of conditioned fear responses |
| Q46162538 | Brain region-specific gene expression activation required for reconsolidation and extinction of contextual fear memory |
| Q47918544 | Bumetanide blocks the acquisition of conditioned fear in adult rats. |
| Q41141060 | Calcium-Permeable AMPA Receptor Dynamics Mediate Fear Memory Erasure |
| Q30410131 | Can fear extinction be enhanced? A review of pharmacological and behavioral findings |
| Q50933420 | Cannabinoid CB1 receptor mediates fear extinction via habituation-like processes. |
| Q36243660 | Cannabinoid facilitation of fear extinction memory recall in humans |
| Q37649879 | Cannabinoid modulation of prefrontal-limbic activation during fear extinction learning and recall in humans |
| Q50635570 | Changes in cue reactivity and attentional bias following experimental cue exposure and response prevention: a laboratory study of the effects of D-cycloserine in heavy drinkers. |
| Q37587742 | Changing fear: the neurocircuitry of emotion regulation |
| Q30443020 | Cholinergic blockade frees fear extinction from its contextual dependency |
| Q30437449 | Chronic antidepressant treatment impairs the acquisition of fear extinction |
| Q92177870 | Clinical Therapeutic Strategy and Neuronal Mechanism Underlying Post-Traumatic Stress Disorder (PTSD) |
| Q35043125 | Cognitive enhancers for anxiety disorders |
| Q35043180 | Cognitive enhancers for facilitating drug cue extinction: insights from animal models |
| Q36498685 | Cognitive processes during fear acquisition and extinction in animals and humans: implications for exposure therapy of anxiety disorders |
| Q95802828 | Combined use of behavioral therapy and partial NMDA agonist to treat anxiety disorders |
| Q28508341 | Concomitant deficits in working memory and fear extinction are functionally dissociated from reduced anxiety in metabotropic glutamate receptor 7-deficient mice |
| Q30433318 | Conditioned fear associated phenotypes as robust, translational indices of trauma-, stressor-, and anxiety-related behaviors |
| Q30450633 | Conditioned fear extinction and reinstatement in a human fear-potentiated startle paradigm |
| Q34159550 | Context, ambiguity, and unlearning: sources of relapse after behavioral extinction |
| Q24658464 | Context-dependent human extinction memory is mediated by a ventromedial prefrontal and hippocampal network |
| Q30496479 | Context-dependent neuronal activity in the lateral amygdala represents fear memories after extinction. |
| Q29615011 | Contributions of the amygdala to emotion processing: from animal models to human behavior |
| Q50900351 | D-Cycloserine and performance under different states of anxiety in healthy volunteers. |
| Q34350942 | D-Cycloserine as an augmentation strategy for cognitive behavioral therapy of anxiety disorders |
| Q33760626 | D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder |
| Q37469098 | D-Cycloserine attenuates reactivity to smoking cues in nicotine dependent smokers: a pilot investigation |
| Q37374323 | D-Cycloserine enhances conditioned taste aversion learning in rats. |
| Q36712113 | D-Cycloserine facilitation of exposure therapy improves weight regain in patients with anorexia nervosa: a pilot randomized controlled trial |
| Q26781321 | D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review |
| Q96229748 | D-Serine as the gatekeeper of NMDA receptor activity: implications for the pharmacologic management of anxiety disorders |
| Q42326066 | D-Serine facilitates the effectiveness of extinction to reduce drug-primed reinstatement of cocaine-induced conditioned place preference |
| Q36764528 | D-cycloserine augmentation of behavioral therapy for the treatment of anxiety disorders: a meta-analysis. |
| Q37642428 | D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial |
| Q24626679 | D-cycloserine deters reacquisition of cocaine self-administration by augmenting extinction learning |
| Q37198881 | D-cycloserine enhances short-delay, but not long-delay, conditioned taste aversion learning in rats |
| Q37036822 | D-cycloserine facilitates context-specific fear extinction learning |
| Q35329570 | D-cycloserine facilitates extinction of cocaine self-administration in C57 mice |
| Q37126364 | D-cycloserine facilitates extinction of naloxone-induced conditioned place aversion in morphine-dependent rats |
| Q46691555 | D-cycloserine facilitates extinction the first time but not the second time: an examination of the role of NMDA across the course of repeated extinction sessions |
| Q35189769 | D-cycloserine facilitates socially reinforced learning in an animal model relevant to autism spectrum disorders |
| Q30479274 | D-cycloserine facilitation of fear extinction and exposure-based therapy might rely on lower-level, automatic mechanisms |
| Q41433830 | D-cycloserine improves synaptic transmission in an animal mode of Rett syndrome |
| Q34926000 | D-cycloserine in prelimbic cortex reverses scopolamine-induced deficits in olfactory memory in rats |
| Q89329928 | D-cycloserine in the treatment of posttraumatic stress disorder |
| Q48088717 | D-cycloserine inhibits amygdala responses during repeated presentations of faces. |
| Q41970731 | D-cycloserine potentiates the reconsolidation of cocaine-associated memories |
| Q35575120 | D-cycloserine reduces neuropathic pain behavior through limbic NMDA-mediated circuitry |
| Q34054882 | D-cycloserine reduces the context specificity of pavlovian extinction of cocaine cues through actions in the nucleus accumbens |
| Q37349926 | D-serine facilitates the effects of extinction to reduce cocaine-primed reinstatement of drug-seeking behavior. |
| Q33764287 | Delayed noradrenergic activation in the dorsal hippocampus promotes the long-term persistence of extinguished fear |
| Q37066415 | Developmental lead exposure impairs extinction of conditioned fear in young adult rats |
| Q34468685 | Different mechanisms of fear extinction dependent on length of time since fear acquisition |
| Q46728968 | Differential roles of basolateral and central amygdala on the effects of uncontrollable stress on hippocampal synaptic plasticity |
| Q37060479 | Dissociable roles for the ventromedial prefrontal cortex and amygdala in fear extinction: NR2B contribution. |
| Q55242704 | Dissociated Role of D-Serine in Extinction During Consolidation vs. Reconsolidation of Context Conditioned Fear. |
| Q31171981 | Does D-cycloserine enhance exposure therapy for anxiety disorders in humans? A meta-analysis |
| Q33835384 | Does d-Cycloserine Augmentation of CBT Improve Therapeutic Homework Compliance for Pediatric Obsessive-Compulsive Disorder? |
| Q39004183 | Dysfunction in amygdala-prefrontal plasticity and extinction-resistant avoidance: A model for anxiety disorder vulnerability |
| Q37553161 | Early postnatal stress and neural circuit underlying emotional regulation |
| Q50628293 | Effect of D-cycloserine and valproic acid on the extinction of reinstated fear-conditioned responses and habituation of fear conditioning in healthy humans: a randomized controlled trial. |
| Q36901973 | Effect of D-cycloserine in conjunction with fear extinction training on extracellular signal-regulated kinase activation in the medial prefrontal cortex and amygdala in rat. |
| Q40974359 | Effects of D-cycloserine on extinction and reconditioning of ethanol-seeking behavior in mice |
| Q35129785 | Effects of D-cycloserine on the extinction of appetitive operant learning |
| Q46934826 | Effects of single prolonged stress and D-cycloserine on contextual fear extinction and hippocampal NMDA receptor expression in a rat model of PTSD. |
| Q39249414 | Emotional Modulation of Learning and Memory: Pharmacological Implications |
| Q36363614 | Emotional learning and glutamate: translational perspectives |
| Q34500045 | Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions |
| Q37683193 | Enhancing Effects of NMDA-Receptor Blockade on Extinction Learning and Related Brain Activation Are Modulated by BMI. |
| Q45215137 | Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear |
| Q22252399 | Enhancing exposure therapy for anxiety disorders with glucocorticoids: From basic mechanisms of emotional learning to clinical applications |
| Q30493574 | Enhancing exposure-based therapy from a translational research perspective |
| Q42718566 | Enhancing the salience of dullness: behavioral and pharmacological strategies to facilitate extinction of drug-cue associations in adolescent rats |
| Q24615107 | Epigenetic mechanisms underlying extinction of memory and drug-seeking behavior |
| Q30394729 | Epigenetics and memory: causes, consequences and treatments for post-traumatic stress disorder and addiction |
| Q36050594 | Erasing fear memories with extinction training. |
| Q37800978 | Evidence‐based treatments for PTSD, new directions, and special challenges |
| Q30382252 | Exercise Augmentation of Exposure Therapy for PTSD: Rationale and Pilot Efficacy Data |
| Q36968757 | Exploring epigenetic regulation of fear memory and biomarkers associated with post-traumatic stress disorder |
| Q90397342 | Exposure Therapy for Post-Traumatic Stress Disorder: Factors of Limited Success and Possible Alternative Treatment |
| Q92534355 | Exposure and Response Prevention in the Treatment of Obsessive-Compulsive Disorder: Current Perspectives |
| Q34110272 | Extinction and renewal of conditioned sexual responses |
| Q48350493 | Extinction of aversive memories associated with morphine withdrawal requires ERK-mediated epigenetic regulation of brain-derived neurotrophic factor transcription in the rat ventromedial prefrontal cortex. |
| Q30478600 | Extinction of drug- and withdrawal-paired cues in animal models: relevance to the treatment of addiction |
| Q48433093 | Extinction training in conjunction with a partial agonist of the glycine site on the NMDA receptor erases memory trace. |
| Q48607780 | Extract of Ginkgo biloba EGb761 facilitates extinction of conditioned fear measured by fear-potentiated startle |
| Q50657116 | Facilitating actions of an AMPA receptor potentiator upon extinction of contextually conditioned fear response in stressed mice |
| Q50913931 | Facilitation of extinction learning for contextual fear memory by PEPA: a potentiator of AMPA receptors. |
| Q51790919 | Facilitation of extinction of operant behaviour in C57Bl/6 mice by chlordiazepoxide and D-cycloserine. |
| Q46378914 | Facilitation of extinction of operant behaviour in mice by D-cycloserine |
| Q37583005 | Facilitation of memory for extinction of drug-induced conditioned reward: role of amygdala and acetylcholine |
| Q57292679 | Fasting enhances extinction retention and prevents the return of fear in humans |
| Q41967620 | Fear erasure in mice requires synergy between antidepressant drugs and extinction training. |
| Q30421426 | Fear extinction as a model for synaptic plasticity in major depressive disorder |
| Q28254365 | Fear extinction as a model for translational neuroscience: ten years of progress |
| Q30365336 | Fear-Potentiated Startle and Fear Extinction in a Sample of Undergraduate Women Exposed to a Campus Mass Shooting. |
| Q30475516 | Fibroblast growth factor-2 enhances extinction and reduces renewal of conditioned fear |
| Q30471721 | From Basic Processes to Real-World Problems: How Research on Emotion and Emotion Regulation Can Inform Understanding of Psychopathology, and Vice Versa |
| Q92127471 | From Extinction Learning to Anxiety Treatment: Mind the Gap |
| Q36287726 | From antipsychotic to anti-schizophrenia drugs: role of animal models |
| Q28682506 | From resilience to vulnerability: mechanistic insights into the effects of stress on transitions in critical period plasticity |
| Q46549433 | From the biology of trauma to secondary preventive pharmalogical measures for post-traumatic stress disorders |
| Q27011901 | From the neurobiology of extinction to improved clinical treatments |
| Q43638610 | Functional interactions between endocannabinoid and CCK neurotransmitter systems may be critical for extinction learning |
| Q30370972 | GABA and NMDA receptors in CRF neurons have opposing effects in fear acquisition and anxiety in central amygdala vs. bed nucleus of the stria terminalis. |
| Q50994186 | Gene-environment interplay in affect and dementia: emotional modulation of cognitive expression in personal outcomes. |
| Q30503573 | Generalization of fear inhibition by disrupting hippocampal protein synthesis-dependent reconsolidation process |
| Q38094638 | Generating new neurons to circumvent your fears: the role of IGF signaling. |
| Q40421959 | Genetic disruptions of Drosophila Pavlovian learning leave extinction learning intact. |
| Q30417488 | Genetic variation in brain-derived neurotrophic factor and human fear conditioning |
| Q39291412 | Genome-wide gene-based analysis suggests an association between Neuroligin 1 (NLGN1) and post-traumatic stress disorder |
| Q48394251 | Glutamate NMDA receptors within the amygdala participate in the modulatory effect of glucocorticoids on extinction of conditioned fear in rats |
| Q24633004 | Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment |
| Q35897264 | Glutamate modulators in the treatment of obsessive-compulsive disorder |
| Q30477927 | Glutamate receptors in extinction and extinction-based therapies for psychiatric illness |
| Q30478963 | Glutamate receptors in the medial geniculate nucleus are necessary for expression and extinction of conditioned fear in rats |
| Q39189451 | Glutamate-modulating drugs as a potential therapeutic strategy in obsessive-compulsive disorder. |
| Q37352930 | Glutamatergic Synaptic Dysfunction and Obsessive-Compulsive Disorder |
| Q35967025 | Glutamatergic agents for OCD and related disorders |
| Q34223138 | Glutamatergic mechanisms associated with stress-induced amygdala excitability and anxiety-related behavior |
| Q38669576 | Glutamatergic regulation of cognition and functional brain connectivity: insights from pharmacological, genetic and translational schizophrenia research |
| Q24648924 | Glutamatergic substrates of drug addiction and alcoholism |
| Q35729062 | Hippocampal Mek/Erk signaling mediates extinction of contextual freezing behavior |
| Q30496579 | Hippocampal regulation of context-dependent neuronal activity in the lateral amygdala |
| Q30456148 | How the neurocircuitry and genetics of fear inhibition may inform our understanding of PTSD. |
| Q38100425 | How to erase memory traces of pain and fear |
| Q50956250 | Identification of AICP as a GluN2C-Selective N-Methyl-d-Aspartate Receptor Superagonist at the GluN1 Glycine Site. |
| Q48368264 | Identification of calcineurin as a key signal in the extinction of fear memory. |
| Q37077248 | Immediate extinction causes a less durable loss of performance than delayed extinction following either fear or appetitive conditioning |
| Q34022949 | Impaired extinction retention in adolescent rats: effects of D-cycloserine |
| Q36900603 | Impaired fear extinction learning and cortico-amygdala circuit abnormalities in a common genetic mouse strain |
| Q36302972 | Implications of learning theory for developing programs to decrease overeating |
| Q37118033 | Implications of memory modulation for post-traumatic stress and fear disorders |
| Q50419972 | Implications of the Research Domain Criteria project for childhood anxiety and its disorders. |
| Q35803307 | Inactivation of the medial prefrontal cortex interferes with the expression but not the acquisition of differential fear conditioning in rats |
| Q47347121 | Infralimbic GluN2A-Containing NMDA Receptors Modulate Reconsolidation of Cocaine Self-Administration Memory |
| Q42488425 | Infralimbic cortex activation increases c-Fos expression in intercalated neurons of the amygdala |
| Q37339742 | Inhibition of Action, Thought, and Emotion: A Selective Neurobiological Review. |
| Q44924131 | Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task |
| Q34175905 | Inhibition of mRNA and protein synthesis in the CA1 region of the dorsal hippocampus blocks reinstallment of an extinguished conditioned fear response |
| Q30418005 | Interacting brain systems modulate memory consolidation |
| Q44785531 | Intra-amygdala administration of polyamines modulates fear conditioning in rats. |
| Q50787501 | Intra-amygdaloid infusion of Ginkgo biloba leaf extract (EGb761) facilitates fear-potentiated startle in rats. |
| Q48859271 | Intraamygdala infusion of fibroblast growth factor 2 enhances extinction and reduces renewal and reinstatement in adult rats |
| Q46521486 | Intranasal oxytocin administration prior to exposure therapy for arachnophobia impedes treatment response |
| Q57816934 | Klassische Konditionierung als Erklärungsprinzip für klinisch bedeutsame Ängste |
| Q48314136 | Lost in translation: how to upgrade fear memory research |
| Q33772516 | Low-dose systemic scopolamine disrupts context conditioning in rats |
| Q90109123 | Making translation work: Harmonizing cross-species methodology in the behavioural neuroscience of Pavlovian fear conditioning |
| Q37414015 | Mechanisms governing the reactivation-dependent destabilization of memories and their role in extinction |
| Q28278209 | Mechanisms of fear extinction |
| Q58557874 | Mechanisms of fear learning and extinction: synaptic plasticity-fear memory connection |
| Q28396555 | Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders |
| Q30469093 | Medial prefrontal cortex activation facilitates re-extinction of fear in rats |
| Q30442026 | Medial prefrontal cortex stimulation modulates the processing of conditioned fear. |
| Q42596408 | Memory extinction requires gene expression in rat hippocampus. |
| Q30502894 | Memory for extinction of conditioned fear is long-lasting and persists following spontaneous recovery |
| Q30460201 | Memory modulation |
| Q30470435 | Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury |
| Q42782469 | Modeling fear-conditioned bradycardia in humans |
| Q38561180 | Modulating fear extinction memory by manipulating SK potassium channels in the infralimbic cortex |
| Q36748119 | Modulation of fear and anxiety by the endogenous cannabinoid system |
| Q40508281 | Molecular mechanisms of D-cycloserine in facilitating fear extinction: insights from RNAseq |
| Q34577044 | Molecular mechanisms of memory reconsolidation |
| Q37748717 | Molecular specificity of multiple hippocampal processes governing fear extinction |
| Q35001313 | Molecular targets in the treatment of anxiety |
| Q37898210 | Mood dysregulation and stabilization: perspectives from emotional cognitive neuroscience |
| Q92897728 | Morbid Anxiety: Identification and Treatment |
| Q48616635 | NMDA Partial agonist reverses blocking of extinction of aversive memory by GABA(A) agonist in the amygdala |
| Q30444033 | NMDA receptor antagonism in the basolateral but not central amygdala blocks the extinction of Pavlovian fear conditioning in rats |
| Q36942831 | NMDA receptor in conditioned flavor-taste preference learning: blockade by MK-801 and enhancement by D-cycloserine |
| Q24604822 | NMDA receptors and fear extinction: implications for cognitive behavioral therapy |
| Q41887030 | Narp knockout mice show normal reactivity to novelty but attenuated recovery from neophobia |
| Q26853333 | Neural and cellular mechanisms of fear and extinction memory formation |
| Q29616240 | Neural mechanisms of extinction learning and retrieval |
| Q26859202 | Neural mechanisms of pain and alcohol dependence |
| Q26796710 | Neurobehavioral perspectives on the distinction between fear and anxiety |
| Q30458551 | Neurobiological correlates of cognitions in fear and anxiety: a cognitive-neurobiological information-processing model |
| Q30453815 | Neuropeptide regulation of fear and anxiety: Implications of cholecystokinin, endogenous opioids, and neuropeptide Y. |
| Q33966168 | Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia |
| Q59791313 | Neuroscience Informed Prolonged Exposure Practice: Increasing Efficiency and Efficacy Through Mechanisms |
| Q38808613 | New Learning and Unlearning: Strangers or Accomplices in Threat Memory Attenuation? |
| Q64218012 | New Pharmacotherapeutic Approaches to Obsessive-Compulsive Disorder |
| Q33598320 | Novel approaches in treatment of pediatric anxiety |
| Q38137924 | Novel pharmacological agents targeting memory and cognition in the treatment of anxiety disorders |
| Q36793074 | Novel treatment approaches for refractory anxiety disorders |
| Q54088077 | Obsessive-compulsive disorder |
| Q44346339 | Opioid receptors in the midbrain periaqueductal gray regulate extinction of pavlovian fear conditioning. |
| Q33740875 | Opposing effects of D-cycloserine on fear despite a common extinction duration: interactions between brain regions and behavior |
| Q47312768 | Perineuronal Nets in the Adult Sensory Cortex Are Necessary for Fear Learning. |
| Q43292774 | Pharmacological discrimination of extinction and reconsolidation of contextual fear memory by a potentiator of AMPA receptors |
| Q34721646 | Pharmacological enhancement of drug cue extinction learning: translational challenges |
| Q22305514 | Pharmacological enhancement of exposure-based treatment in PTSD: a qualitative review |
| Q30462825 | Pharmacological enhancement of fear reduction: preclinical models. |
| Q34661221 | Pharmacological enhancement of memory and executive functioning in laboratory animals. |
| Q24633256 | Pharmacological treatment of PTSD - established and new approaches |
| Q38242548 | Pharmacological treatment of obsessive-compulsive disorder |
| Q30480038 | Pharmacological treatments that facilitate extinction of fear: relevance to psychotherapy |
| Q27006437 | Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders |
| Q38217123 | Pharmacotherapy in the aftermath of trauma; opportunities in the 'golden hours'. |
| Q30476116 | Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear |
| Q35194637 | Positive emotional learning is regulated in the medial prefrontal cortex by GluN2B-containing NMDA receptors. |
| Q47321863 | Post-reexposure administration of D-cycloserine facilitates reconsolidation of contextual conditioned fear memory in rats |
| Q37491564 | Potentiation of GluN2C/D NMDA receptor subtypes in the amygdala facilitates the retention of fear and extinction learning in mice. |
| Q35972373 | Preclinical perspectives on posttraumatic stress disorder criteria in DSM-5. |
| Q46644369 | Prefrontal control of the amygdala. |
| Q42682280 | Previous stress attenuates the susceptibility to Midazolam's disruptive effect on fear memory reconsolidation: influence of pre-reactivation D-cycloserine administration |
| Q33948145 | Propranolol and D-cycloserine as adjunctive medications in reducing dental fear in sedation practice |
| Q46370723 | Protein kinase A-dependent enhanced NMDA receptor function in pain-related synaptic plasticity in rat amygdala neurones |
| Q37563543 | Psychotherapy for obsessive-compulsive disorder |
| Q37667486 | Randomized placebo-controlled D-cycloserine with cognitive behavior therapy for pediatric posttraumatic stress |
| Q36261186 | Randomized, Placebo-Controlled, Double-Blind Pilot Study of D-Cycloserine in Chronic Stroke |
| Q30437452 | Rapid remission of conditioned fear expression with extinction training paired with vagus nerve stimulation |
| Q37578425 | Reconsolidation and extinction are dissociable and mutually exclusive processes: behavioral and molecular evidence |
| Q34569427 | Reconsolidation and extinction of conditioned fear: inhibition and potentiation. |
| Q37985308 | Reconsolidation of drug memories |
| Q33813007 | Regulation of Fear Extinction in the Basolateral Amygdala by Dopamine D2 Receptors Accompanied by Altered GluR1, GluR1-Ser845 and NR2B Levels |
| Q34081207 | Regulation of extinction-related plasticity by opioid receptors in the ventrolateral periaqueductal gray matter |
| Q35970477 | Relapse processes after the extinction of instrumental learning: renewal, resurgence, and reacquisition |
| Q36002692 | Remembering another aspect of forgetting |
| Q89357277 | Reproductive experience alters the involvement of N-methyl-D-aspartate receptors in fear extinction, but not fear conditioning, in female Sprague Dawley rats |
| Q26776255 | Rethinking psychopharmacotherapy: The role of treatment context and brain plasticity in antidepressant and antipsychotic interventions |
| Q36216384 | Retrieval and the extinction of memory. |
| Q37350962 | Risk for anxiety and implications for treatment: developmental, environmental, and genetic factors governing fear regulation |
| Q36625570 | Role of L-type Ca2+ channel isoforms in the extinction of conditioned fear |
| Q30498732 | Role of corticotropin releasing factor in anxiety disorders: a translational research perspective |
| Q35118415 | Role of the Amygdala in Fear Extinction Measured with Potentiated Startle |
| Q30466738 | Seeking a spotless mind: extinction, deconsolidation, and erasure of fear memory |
| Q37634056 | Single prolonged stress: toward an animal model of posttraumatic stress disorder |
| Q89963667 | Social Company by a Receptive Mating Partner Facilitates Fear Extinction |
| Q36799002 | State-Dependent Partial Occlusion of Cortical LTP-Like Plasticity in Major Depression |
| Q34283226 | Stimulation of serotonin 2A receptors facilitates consolidation and extinction of fear memory in C57BL/6J mice. |
| Q30366954 | Stress and Fear Extinction. |
| Q26769043 | Stress as a one-armed bandit: Differential effects of stress paradigms on the morphology, neurochemistry and behavior in the rodent amygdala |
| Q30464319 | Stress modulation of cognitive and affective processes |
| Q35957258 | Stress-induced impairments in prefrontal-mediated behaviors and the role of the N-methyl-D-aspartate receptor |
| Q33821292 | Structural determinants of D-cycloserine efficacy at the NR1/NR2C NMDA receptors |
| Q41194121 | Successful pharmacotherapy for the treatment of severe feeding aversion with mechanistic insights from cross-species neuronal remodeling. |
| Q30493920 | Synaptic correlates of fear extinction in the amygdala |
| Q28242702 | Synaptic plasticity: multiple forms, functions, and mechanisms |
| Q46736604 | Systemic and intra-amygdala administration of glucocorticoid agonist and antagonist modulate extinction of conditioned fear |
| Q28265467 | Systemic blockade of D2-like dopamine receptors facilitates extinction of conditioned fear in mice |
| Q44416478 | Systemic or intra‐amygdala injections of glucose facilitate memory consolidation for extinction of drug‐induced conditioned reward |
| Q34122994 | Tailoring therapeutic strategies for treating posttraumatic stress disorder symptom clusters |
| Q24647348 | Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic |
| Q27016155 | Targeting memory processes with drugs to prevent or cure PTSD |
| Q30525198 | Testing the effects of Δ9-THC and D-cycloserine on extinction of conditioned fear in humans |
| Q42092178 | The L-type calcium channel blocker nifedipine impairs extinction, but not reduced contingency effects, in mice |
| Q37089890 | The NMDA agonist D-cycloserine facilitates fear memory consolidation in humans |
| Q41476154 | The NMDA receptor partial agonist d-cycloserine does not enhance motor learning |
| Q57407197 | The Neurobiology and Pharmacotherapy of Posttraumatic Stress Disorder |
| Q50138246 | The Role of Serine Racemase in the Pathophysiology of Brain Disorders |
| Q36800822 | The application of exposure therapy and D-cycloserine to the treatment of anorexia nervosa: a preliminary trial |
| Q50926779 | The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats. |
| Q36456733 | The effect of D-cycloserine on subliminal cue exposure in spider fearful individuals |
| Q43186668 | The effect of Midazolam and Propranolol on fear memory reconsolidation in ethanol-withdrawn rats: influence of d-cycloserine. |
| Q47555330 | The effect of ketamine on the consolidation and extinction of contextual fear memory |
| Q34412442 | The effect of the mGlu5 negative allosteric modulator MTEP and NMDA receptor partial agonist D-cycloserine on Pavlovian conditioned fear. |
| Q36227610 | The effects of extinction training in reducing the reinstatement of drug-seeking behavior: involvement of NMDA receptors |
| Q37217230 | The effects of yohimbine and amphetamine on fear expression and extinction in rats. |
| Q46434328 | The facilitative effects of D-cycloserine on extinction of a cocaine-induced conditioned place preference can be long lasting and resistant to reinstatement |
| Q45027852 | The inhibition of acquired fear |
| Q35963247 | The promise of extinction research for the prevention and treatment of anxiety disorders |
| Q35001310 | The role of glutamate and gamma-aminobutyric acid in fear extinction: clinical implications for exposure therapy |
| Q31029023 | The role of glutamate in anxiety and related disorders |
| Q24605193 | The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder |
| Q26779278 | The role of serotonin 5-HT2A receptors in memory and cognition |
| Q50638340 | The role of the dorsal hippocampus on the Ginkgo biloba facilitation effect of fear extinction as assessed with fear-potentiated startle. |
| Q30417829 | The role of the medial prefrontal cortex in regulating social familiarity-induced anxiolysis. |
| Q21342971 | The role of the medial prefrontal cortex-amygdala circuit in stress effects on the extinction of fear |
| Q33988524 | The study of fear extinction: implications for anxiety disorders |
| Q34352202 | Thy1-expressing neurons in the basolateral amygdala may mediate fear inhibition |
| Q37116414 | Towards a theory of chronic pain. |
| Q30437494 | Towards new approaches to disorders of fear and anxiety |
| Q36744289 | Training-induced changes in the expression of GABAA-associated genes in the amygdala after the acquisition and extinction of Pavlovian fear |
| Q89958362 | Translating Across Circuits and Genetics Toward Progress in Fear- and Anxiety-Related Disorders |
| Q37076103 | Translating findings from basic fear research to clinical psychiatry in Puerto Rico |
| Q38992288 | Using model systems to understand errant plasticity mechanisms in psychiatric disorders |
| Q30428273 | Using the conditioned fear stress (CFS) animal model to understand the neurobiological mechanisms and pharmacological treatment of anxiety |
| Q42364462 | Vagus Nerve Stimulation Enhances Extinction of Conditioned Fear in Rats and Modulates Arc Protein, CaMKII, and GluN2B-Containing NMDA Receptors in the Basolateral Amygdala. |
| Q57170309 | Vagus nerve stimulation as a tool for enhancing extinction in exposure-based therapies |
| Q37873376 | Virtual reality goes to war: a brief review of the future of military behavioral healthcare |
| Q48029863 | Vorinostat ameliorates impaired fear extinction possibly via the hippocampal NMDA-CaMKII pathway in an animal model of posttraumatic stress disorder |
| Q36920066 | What does it take to demonstrate memory erasure? Theoretical comment on Norrholm et al. (2008). |
| Q34872584 | Why behavior change is difficult to sustain |
| Q87661914 | [New developments in the psychotherapeutic and pharmacological treatment of pediatric obsessivecompulsive disorder] |
| Q30404599 | d-Cycloserine augmentation of cognitive remediation in schizophrenia |
| Q35787895 | d-cycloserine reverses the detrimental effects of stress on learning in females and enhances retention in males |
| Q30486477 | mGluR5 has a critical role in inhibitory learning. |
| Q51795193 | mGluR7 facilitates extinction of aversive memories and controls amygdala plasticity. |
Search more.